Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Placebo 400 mg (dietary_supplement)
• Dihydroberberine（DHB）400 mg (dietary_supplement)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Merieux NutriSciences
  Addison, Illinois, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• XTL6001 (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Beijing Shijitan Hospital, Capital Medical University
  Beijing, Beijing Municipality, China
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Glucagon (drug)
• Glucagon+Exendin9-39 (drug)
• Sodium chloride (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tocilizumab (drug)
• Placebo (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University Hospital Basel
  Basel, Switzerland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide Dose 1 (drug)
• Tirzepatide Dose 2 (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Children's Hospital Los Angeles
  Los Angeles, California, United States
  Site recruitment: Not reported
• Center Of Excellence in Diabetes and Endocrinology
  Sacramento, California, United States
  Site recruitment: Not reported
• Rady Children's Hospital
  San Diego, California, United States
  Site recruitment: Not reported
• Touro University California
  Vallejo, California, United States
  Site recruitment: Not reported
• Children's Hospital Colorado
  Aurora, Colorado, United States
  Site recruitment: Not reported
• Nemours Children's Health - Delaware
  Wilmington, Delaware, United States
  Site recruitment: Not reported
• Qualmedica Research, LLC
  Evansville, Indiana, United States
  Site recruitment: Not reported
• Indiana University Health University Hospital
  Indianapolis, Indiana, United States
  Site recruitment: Not reported
• AA Medical Research Center
  Flint, Michigan, United States
  Site recruitment: Not reported
• Washington University School of Medicine
  St Louis, Missouri, United States
  Site recruitment: Not reported
• SUNY Upstate Medical University
  Syracuse, New York, United States
  Site recruitment: Not reported
• Children's Hospital of Philadelphia (CHOP)
  Philadelphia, Pennsylvania, United States
  Site recruitment: Not reported
• Consano Clinical Research, LLC
  Shavano Park, Texas, United States
  Site recruitment: Not reported
• The Children's Hospital at Westmead
  Westmead, New South Wales, Australia
  Site recruitment: Not reported
• Centre for Children's Health Research
  Brisbane, Queensland, Australia
  Site recruitment: Not reported
• Perth Children's Hospital
  Perth, Western Australia, Australia
  Site recruitment: Not reported
• CEDOES
  Vitória, Espírito Santo, Brazil
  Site recruitment: Not reported
• Centro de Diabetes Curitiba
  Curitiba, Paraná, Brazil
  Site recruitment: Not reported
• Instituto Méderi de Pesquisa e Saúde
  Passo Fundo, Rio Grande do Sul, Brazil
  Site recruitment: Not reported
• Instituto da Crianca com Diabetes
  Porto Alegre, Rio Grande do Sul, Brazil
  Site recruitment: Not reported
• Centro de Pesquisa Sao Lucas
  Campinas, São Paulo, Brazil
  Site recruitment: Not reported
• Instituto de Pesquisa clinica de Campinas
  Campinas, São Paulo, Brazil
  Site recruitment: Not reported
• Instituto de Pesquisa Clinica
  São Paulo, São Paulo, Brazil
  Site recruitment: Not reported
• Instituto da Crianca do Hospital das Clinicas da FMUSP
  São Paulo, São Paulo, Brazil
  Site recruitment: Not reported
• Ruschel Medicina e Pesquisa Clínica
  Rio de Janeiro, Brazil
  Site recruitment: Not reported
• CPQuali Pesquisa Clínica
  São Paulo, Brazil
  Site recruitment: Not reported
• CEPIC - Centro Paulista de Investigação Clínica
  São Paulo, Brazil
  Site recruitment: Not reported
• Centre Hospitalier Universitaire d'Angers
  Angers, Maine-et-Loire, France
  Site recruitment: Not reported
• Assistance Publique - Hopitaux de Paris (AP-HP) - Hopital Robert Debre - Centre Hospitalo Universitaire (C -T
  Paris, France
  Site recruitment: Not reported
• Gujarat Endocrin Pvt Ltd
  Ahmedabad, Gujarat, India
  Site recruitment: Not reported
• M S Ramaiah Medical College and Hospitals
  Bangalore, Karnataka, India
  Site recruitment: Not reported
• Bhakti Vedanta Hospital and Research Institute
  Thane, Maharashtra, India
  Site recruitment: Not reported
• All India Institute of Medical Sciences
  New Delhi, National Capital Territory of Delhi, India
  Site recruitment: Not reported
• Kovai Diabetes Speciality Center and Hospital
  Coimbatore, Tamil Nadu, India
  Site recruitment: Not reported
• Postgraduate Institute of Medical Education & Research
  Chandigarh, India
  Site recruitment: Not reported
• Yitzhak Shamir Medical Center
  Be’er Ya‘aqov, Central District, Israel
  Site recruitment: Not reported
• Sheba Medical Center
  Ramat Gan, Central District, Israel
  Site recruitment: Not reported
• Shaare Zedek Medical Center
  Jerusalem, Jerusalem, Israel
  Site recruitment: Not reported
• Rambam Health Care Campus
  Haifa, Northern District, Israel
  Site recruitment: Not reported
• Soroka Medical Center
  Beersheba, Southern District, Israel
  Site recruitment: Not reported
• Azienda Ospedaliera Universitaria dell'Università "Luigi Vanvitelli" Piazza Luigi Miraglia, 2 Napoli Campa -T
  Naples, Campania, Italy
  Site recruitment: Not reported
• Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento
  Verona, Veneto, Italy
  Site recruitment: Not reported
• Ospedale Pediatrico Salesi
  Ancona, Italy
  Site recruitment: Not reported
• Unidad Médica para la Salud Integral
  San Nicolás de los Garza, Nuevo León, Mexico
  Site recruitment: Not reported
• Clínica Cemain
  Tampico, Tamaulipas, Mexico
  Site recruitment: Not reported
• Investigacion En Salud Y Metabolismo Sc
  Chihuahua City, Mexico
  Site recruitment: Not reported
• Consultorio Médico de Endocrinología y Pediatría
  Puebla City, Mexico
  Site recruitment: Not reported
• Arké SMO S.A de C.V
  Veracruz, Mexico
  Site recruitment: Not reported
• Leicester Royal Infirmary
  Leicester, England, United Kingdom
  Site recruitment: Not reported
• Hull Royal Infirmary
  Hull, Kingston Upon Hull, United Kingdom
  Site recruitment: Not reported
• Leicester General Hospital
  Leicester, Leicestershire, United Kingdom
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• HDM1002 200 mg (drug)
• HDM1002 400 mg (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Peking University People's Hospital
  Beijing, Beijing Municipality, China
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Bimagrumab (drug) — also listed as: LY3985863
• Tirzepatide (drug) — also listed as: LY3298176
• Bimagrumab Placebo (drug)
• Tirzepatide Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Yuma Clinical Trials
  Yuma, Arizona, United States
  Site recruitment: Not reported
• Orange County Research Center
  Lake Forest, California, United States
  Site recruitment: Not reported
• Healthy Brain Clinic
  Long Beach, California, United States
  Site recruitment: Not reported
• Valley Clinical Trials, Inc.
  Northridge, California, United States
  Site recruitment: Not reported
• Diablo Clinical Research, Inc.
  Walnut Creek, California, United States
  Site recruitment: Not reported
• Excel Medical Clinical Trials
  Boca Raton, Florida, United States
  Site recruitment: Not reported
• Clinical Neuroscience Solutions, Inc. dba CNS Healthcare
  Jacksonville, Florida, United States
  Site recruitment: Not reported
• L&C Professional Medical Research Institute
  Miami, Florida, United States
  Site recruitment: Not reported
• Global Health Research Center, Inc.
  Miami Lakes, Florida, United States
  Site recruitment: Not reported
• Charter Research - Winter Park
  Orlando, Florida, United States
  Site recruitment: Not reported
• Charter Research - Lady Lake
  The Villages, Florida, United States
  Site recruitment: Not reported
• Balanced Life Health Care Solutions/SKYCRNG
  Lawrenceville, Georgia, United States
  Site recruitment: Not reported
• East-West Medical Research Institute
  Honolulu, Hawaii, United States
  Site recruitment: Not reported
• Bingham Memorial Hospital
  Blackfoot, Idaho, United States
  Site recruitment: Not reported
• Family First Medical Center
  Idaho Falls, Idaho, United States
  Site recruitment: Not reported
• Deaconess Clinic- Gateway
  Newburgh, Indiana, United States
  Site recruitment: Not reported
• Kur Research - Columbia Medical
  Columbia, Maryland, United States
  Site recruitment: Not reported
• Great Lakes Research Group, Inc.
  Bay City, Michigan, United States
  Site recruitment: Not reported
• University of North Carolina Medical Center
  Chapel Hill, North Carolina, United States
  Site recruitment: Not reported
• Remington-Davis, Inc
  Columbus, Ohio, United States
  Site recruitment: Not reported
• Central States Research
  Tulsa, Oklahoma, United States
  Site recruitment: Not reported
• Velocity Clinical Research, Dallas
  Dallas, Texas, United States
  Site recruitment: Not reported
• PlanIt Research, PLLC
  Houston, Texas, United States
  Site recruitment: Not reported
• Activian Clinical Research
  Kingwood, Texas, United States
  Site recruitment: Not reported
• Northwest Clinical Research Center
  Bellevue, Washington, United States
  Site recruitment: Not reported
• CIPREC
  Buenos Aires, Buenos Aires F.D., Argentina
  Site recruitment: Not reported
• Centro Médico Viamonte
  Buenos Aires, Buenos Aires F.D., Argentina
  Site recruitment: Not reported
• Consultorio de Investigación Clínica EMO SRL
  Buenos Aires, Buenos Aires F.D., Argentina
  Site recruitment: Not reported
• CIPREC
  Buenos Aires, Argentina
  Site recruitment: Not reported
• Richmond Clinical Trials
  Richmond, British Columbia, Canada
  Site recruitment: Not reported
• Centricity Research Brampton Endocrinology
  Brampton, Ontario, Canada
  Site recruitment: Not reported
• Premier Clinical Trial Network
  Hamilton, Ontario, Canada
  Site recruitment: Not reported
• Your Research Network
  Niagara Falls, Ontario, Canada
  Site recruitment: Not reported
• Centricity Research Pointe-Claire Multispecialty
  Pointe-Claire, Quebec, Canada
  Site recruitment: Not reported
• Diex Recherche Trois-Rivieres
  Trois-Rivières, Quebec, Canada
  Site recruitment: Not reported
• Diex Recherche Quebec
  Québec, Canada
  Site recruitment: Not reported
• The Fourth Affiliated Hospital of Harbin Medical University
  Harbin, Heilongjiang, China
  Site recruitment: Not reported
• The First Affiliated Hospital of Henan University of Science &Technology
  Luoyang Shi, Henan, China
  Site recruitment: Not reported
• The Second Affiliated Hospital of Nanjing Medical University
  Nanjing, Jiangsu, China
  Site recruitment: Not reported
• The First Affiliated Hospital of Soochow University
  Suzhou, Jiangsu, China
  Site recruitment: Not reported
• Jinan Central Hospital
  Jinan, Shandong, China
  Site recruitment: Not reported
• Shanghai Sixth People's Hospital
  Shanghai, Shanghai Municipality, China
  Site recruitment: Not reported
• Tokuyama Clinic
  Mihama-ku,Chiba City, Chiba, Japan
  Site recruitment: Not reported
• Hayashi Diabetes Internal Medicine Clinic
  Chigasaki, Kanagawa, Japan
  Site recruitment: Not reported
• Shonan Takai Clinic
  Kamakura, Kanagawa, Japan
  Site recruitment: Not reported
• Takai Internal Medicine Clinic
  Kamakura-shi, Kanagawa, Japan
  Site recruitment: Not reported
• Medical Corporation Heishinkai OCROM Clinic
  Suita-shi, Osaka, Japan
  Site recruitment: Not reported
• The Institute of Medical Science, Asahi Life Foundation
  Chuo-ku, Tokyo, Japan
  Site recruitment: Not reported
• Tokyo-Eki Center-building Clinic
  Chuo-ku, Tokyo, Japan
  Site recruitment: Not reported
• Fukuwa Clinic
  Chuo-ku, Tokyo, Japan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Exenatide Implant (combination_product) — also listed as: NPM115/NPM119
• Bydureon BCise (exenatide extended release) (drug)
• Semaglutide, 1.0 mg/mL (drug) — also listed as: Wegovy, Ozempic

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• CMax
  Adelaide, Australia
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Exercise Test (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• lixisenatide + glargine (drug) — also listed as: GLP-1 plus basal insulin
• Intensive insulin therapy (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Warsaw Medical University
  Warsaw, Warsaw, Poland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (Rybelsus®) (drug)
• Tirzepatide (drug)
• Standardized Lifestyle Intervention (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Enobosarm (drug)
• Semaglutide (drug) — also listed as: Wegovy

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Pinnacle Trials
  Anniston, Alabama, United States
  Site recruitment: Not reported
• Cullman Clinical Trials
  Cullman, Alabama, United States
  Site recruitment: Not reported
• Artemis Institute for Clinical Research
  San Diego, California, United States
  Site recruitment: Not reported
• Universal Axom Clinical Research
  Doral, Florida, United States
  Site recruitment: Not reported
• Altus Research
  Lake Worth, Florida, United States
  Site recruitment: Not reported
• MARC Research Center
  Louisville, Kentucky, United States
  Site recruitment: Not reported
• Pennington Biomedical
  Baton Rouge, Louisiana, United States
  Site recruitment: Not reported
• DelRicht Research - New Orleans
  New Orleans, Louisiana, United States
  Site recruitment: Not reported
• Centennial Medical Group (CMG)
  Elkridge, Maryland, United States
  Site recruitment: Not reported
• SKY Integrative Medical Center
  Ridgeland, Mississippi, United States
  Site recruitment: Not reported
• Clinvest Headlands LLC
  Springfield, Missouri, United States
  Site recruitment: Not reported
• Palm Research Center
  Las Vegas, Nevada, United States
  Site recruitment: Not reported
• Lillestol Research LLC
  Fargo, North Dakota, United States
  Site recruitment: Not reported
• Clinical Trials of Texas, LLC DBA Flourish Research
  San Antonio, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Children's Minnesota
  Saint Paul, Minnesota, United States
  Site recruitment: Recruiting
• Vanderbilt University Medical Center
  Nashville, Tennessee, United States
  Site recruitment: Recruiting
• Seattle Children's Hospital
  Seattle, Washington, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP-1 (drug)
• CBTe Group Therapy (behavioral)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Haukeland University Hospital
  Bergen, Vestland, Norway
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Ecnoglutide (drug) — also listed as: XW003
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Nanjing Drum Tower Hospital
  Nanjing, Jiangsu, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Exendin-(9-39) (drug) — also listed as: No other name for Exendin-(9-39)
• Atropine (drug) — also listed as: Atropine sulfate
• GLP-1 and GIP (drug) — also listed as: No other names for GLP-1 and GIP.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Texas Diabetes Institute - University Health System
  San Antonio, Texas, United States
  Site recruitment: Recruiting
• South Texas Veterans Health Care System
  San Antonio, Texas, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Intravenous Infusion (other)
• Intravenous Infusion (other)
• Intravenous Infusion (other)
• Intravenous Infusion (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Center for Clinical Metabolic Research, Gentofte Hospital
  Hellerup, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Semaglutide (drug) — also listed as: Glucagon-like peptide-1 receptor (GLP1-R) agonist, Wegovy
• Phentermine-Topiramate combination (drug) — also listed as: Qsymia
• Phentermine (drug) — also listed as: Lomaira, Adipex-P
• Tirzepatide (drug) — also listed as: Mounjaro, Zepbound, GIP/GLP-1 RA
• Topiramate (drug) — also listed as: Topamax, Trokendi XR, Qudexy XR
• Diethylpropion (drug) — also listed as: Tenuate, Diethylcathinone
• Naltrexone/Bupropion (drug) — also listed as: Contrave
• Liraglutide (drug) — also listed as: Saxenda, Victoza, Glucagon-like peptide-1 receptor (GLP1-R) agonist

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO
  New Orleans, Louisiana, United States
  Site recruitment: Not reported
• Ochsner Health System - Biospecimen
  New Orleans, Louisiana, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• exendin-(9-39) (drug) — also listed as: no other name for exendin-(9-39)
• exendin -(9-39) (drug) — also listed as: no other name for exendin-(9-39)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Texas Diabetes Institute - University Health System
  San Antonio, Texas, United States
  Site recruitment: Recruiting
• South Texas Veterans Health Care System
  San Antonio, Texas, United States
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Tirzepatide (drug) — also listed as: Mounjaro
• Usual care medications (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Michigan
  Ann Arbor, Michigan, United States
  Site recruitment: Recruiting